|
|
|
|
|
|
|
|
|
Event Name:
BIOTECHNICA
|
|
|
|
|
|
|
|
|
|
From: October 7, 2008
|
|
|
|
|
|
|
|
|
|
To: October 9, 2008
|
|
|
|
|
|
|
|
|
|
Place:
Hannover, Germany
|
|
|
|
|
|
|
|
|
|
Event Description:
BIOTECHNICA is regarded as the leading event of the
year for the European biotech industry, covering all sectors of biotechnology in
depth - from basic biotechnology research, equipment, bioinformatics and services
to the five principal areas of application - pharmaceuticals and medicine, industry,
nutrition, agriculture and the environment. But BIOTECHNICA is far more than just
a trade show and exhibition.
With its many conventions and specialized events it offers exhibitors and visitors
a central platform for knowledge transfer.
Four main elements create a sound basis for effective networking and business:
§
Exhibition
§
Conference program
§
BIOTECHNICA PARTNERING
§
EUROPEAN BIOTECHNICA AWARD
The conferences in 2008 represent an integral part
of the BIOTECHNICA event and considerably contribute to establish it as the European
meeting platform for biotechnology. This years' conference program with its top-class
speakers is structured into three areas, which represent the central themes throughout
the entire event:
§
BioScience/BioPerspectives
§
BioBusiness
§
BioPolitics
Outstanding in the focus area of BioScience 2008 is
the
European BioPerspectives, which takes place
for the first time parallel to BIOTECHNICA in
Hannover
with an expected 2,000 delegates on site.
|
|
|
|
|
|
|
|
|
|
Contact: Andrea Busch, Deutsche Messe,
Messegelände, 30521
Hannover
GERMANY
|
|
|
|
|
|
|
|
|
|
Phone: +49 511 89-31288
|
|
|
|
|
|
|
|
|
|
Fax: +49 511 89-30998
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Event Name :BIO Taiwan 2008
July 24 (Thu) ~ July 27 (Sun), 2008
World Trade Center Exhibition Hall 1
Event Profile:
The year 2007 is a break-though for
Taiwan
’s biotechnology and pharmaceutical industry. A statue to encourage development
of the biotech and pharmaceutical industry was passed in June, offering incentives
to boost one of the nation's most promising sectors. The statue, put into effect
in July 2007 and to expire in the end of 2021, includes incentives and improvement
over four areas: business tax, professional manpower recruitment, product review
efficiency and industry upgrade. Addressing the opening ceremony of BioTaiwan 2007,
Premier Chang of the Executive Yuan noted that the government will invest more than
600 million USD along with 1 billion USD from private venture investment to promote
the development of biotech industry, hoping to create another “trillion industry”
following the triumph of the country’s IT industry. With the government’s strong
support and active participation from the biotech community, BioTaiwan has become
the largest event for the biotechnology industry in Asia Pacific. Attracting more
than ever exhibitors and increased international media attention, BioTaiwan 2007
was a phenomenal success.
Contact:
Chan Chao International Co,. LTD.
3F. No. 185, KangChien Rd., Nei-Hu Dist, Taipei, Taiwan
TEL：886-2-2659-6000
FAX：886-2-2659-7000
E-mail：bioclub@chanchao.com.tw
|
|
|
|
|
Event Name :
The World's
Drug Discovery Meeting Place
World Trade
Center
Boston
& Seaport hotel,
Boston, MA
.
August 4 – 7 2008
.
Drug Discovery & Development of Innovative Therapeutics
is the premier conference and exhibition reflecting the ultimate goal of the pharmaceutical
and biotechnology industries which is to bring innovative medicines to the marketplace.
Now in its 13th year, this event provides a meeting place
for 3,000+ attendees to engage in scientific debate and develop business partnerships
and networking contacts. The 200+ booth exhibit hall provides a one-stop shop for
evaluating new technologies and products from early discovery to clinical development.
Drug Discovery & Development of Innovative Therapeutics includes a comprehensive
conference of over 200 speakers from top pharmaceutical and biotechnology companies
and government and academic research labs.
This event is designed to highlight faster and more efficient
approaches to discovery and development that may not follow traditional models.
It will highlight numerous case studies of how companies are moving from discovery
to the clinic in creative ways and with less resources. It will have a special emphasis
on how drug discovery and development is being done by smaller and mid-size companies
in non-traditional ways and will help you to challenge the conventional wisdom of
drug discovery and look at new approaches and new ways of thinking.
Website:- http://www.drugdisc.com |
|
|
|
|
Event Name : BIO Investor Conference 2008
The annual biotechnology investor conference
featuring private and small to mid-cap public growth companies.
October 29-31, 2008
Palace Hotel,
San Francisco
Background: The
5th Annual BIO Investor Forum will showcase to the investor community public and
venture-stage growth companies as well as those poised to join the growth “watch
list” in the coming year.
Highlights:
- Over 225 public
and venture-stage company presentations
- Therapeutic
workshops focusing on drug and technology developments
- Business roundtables
focusing on the latest market and investment opportunities
- One-on-One investor
meetings
- Networking with
top industry executives and investors focused exclusively on life sciences
Biotechnology Industry Organization
1201
Maryland
Avenue, SW
Suite 900
Washington
, DC 20024
202.962.9200 (p)
202.488.6301 (f)
info@bio.org
|
|
|
|
|
Event Name : 7Th INT'L BIO FORUM &
BIO EXPO
JAPAN
July 2- 4 2008.
Tokyo
Big Sight
Japan
.
7Th
INT'L BIO FORUM & BIO EXPO
JAPAN
is
ASIA
'S LARGEST
BIO EVENT with 650 exhibitors and 21,000 visitors. The 250 sessions/seminars also
attract strong attention as the best place for enhancing knowledge on life science.
This event is widely known as a comprehensive bio event gathering all bio-related
people, products, technologies and information from all across
Asia
.
Concurrent
Events:-
BioVenture Forum
This forum
is for small/medium, start-up companies with:
Seeds/ingredients for new drugs/supplements
Drug discovery-supporting technologies
New
materials for bioresearch devices etc
to help
find partnerships in licensing, research collaborations and financial support with/from:
- Pharmaceutical
manufacturers
- Food manufacturers
- Chemical manufacturers
- Bio-related companies etc.
Conference:-
This year
we had a Keynote and 10 Special Sessions providing cutting-edge research technologies
and industry trends. Topics include:
- Post
Genome Sequencing
- VC and Partnering
- Nano-biotechnology
- Functional RNA
- Application of human ES Cells
- Personalized
medicine
- Intellectual properties
- Functional food
- Pharmaceutical regulations
Contact:-
INT'L BIO FORUM & BIO EXPO JAPAN Show Management
Reed Exhibitions Japan Ltd.
Hajime Suzuki, Chisato Miyawaki, Bong John
18F Shinjuku-Nomura Bldg.,1-26-2
Nishishinjuku,Shinjuku-ku,Tokyo 163-0570,Japan
TEL.+81-3-3349-8509 FAX.+81-3-3349-4922
E-mail：bioexpo@reedexpo.co.jp
|
|
|
|
|
Event Name : BioEquity Europe 2008.
May 28-29, 2008
Hotel Okura
Amsterdam
, the
Netherlands
More than eight years ago, BioCentury, EBD Group and BIO
joined with our like-minded
collaborators in the international banking and venture communities to launch BioEquity Europe, a forum singularly focused on the financial health of European
biotech.
Building on its growing successes in
Munich
,
Frankfurt
,
Zurich
,
Paris
,
Edinburgh
and
Glasgow
, BioEquity Europe comes to
Amsterdam
for its 9th anniversary event, offering
an unparalleled showcase of investment opportunities at a critical time in the history
of European life sciences.
Celebrating its 9th anniversary, BioEquity Europe has established itself
as the magnet for financial dealmakers and the premier venue for life science companies
positioning themselves to attract capital from international investors.
The challenge for investors — both specialists and generalists — will be identifying
top quality companies with forward momentum. In this setting, BioEquity
Europe 2008
convenes in
Amsterdam
with a programme uniquely designed
to address the desire of European money managers to invest on a global scale.
We are pleased to recognize the Regional Host NYSE Euronext and Gold Equity Sponsor
Nomura Phase4 Ventures for their generous support of the 2008 conference.
Sponsorhips:-
Eric Pierce
ericpierce@biocentury.com
Tel: +1 (312) 755-0798
General Info:-
Bill Weyeneth
Manager, Conferences
wcweyeneth@biocentury.com
Tel: +1 (650) 595-5333
Fax: +1 (650) 595-5589
|
|
|
|